ZNTL250117C15000
- 2.40
- 0.000.00%
Zentalis Pharmaceuticals Newsroom
Lexeo Therapeutics Appoints Kyle Rasbach as CFO
Zentalis Pharmaceuticals Appoints Wendy Chang as Chief People Officer and Haibo Wang as Chief Business Officer
Zentalis Pharmaceuticals Appoints Wendy Chang as Chief People Officer >ZNTL
Press Release: Zentalis Pharmaceuticals Announces Key Management Appointments
Express News | Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Press Release: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Guggenheim Maintains Zentalis Pharmaceuticals(ZNTL.US) With Buy Rating, Cuts Target Price to $8
A Quick Look at Today's Ratings for Zentalis Pharmaceuticals(ZNTL.US), With a Forecast Between $8 to $20
Express News | Zentalis Pharmaceuticals Inc : Guggenheim Cuts Target Price to $8 From $12
Express News | HC Wainwright & Co. Reiterates Buy on Zentalis Pharma, Maintains $20 Price Target
Zentalis Pharma Analyst Ratings
A Quick Look at Today's Ratings for Zentalis Pharmaceuticals(ZNTL.US), With a Forecast Between $8 to $9
Cautious Hold on Zentalis Pharmaceuticals Amid Strategic Shifts and Safety Concerns
Zentalis Pharmaceuticals: Strong Leadership and Promising Clinical Developments Justify Buy Rating
Zentalis Pharmaceuticals Announces Julie Eastland Appointed Chief Executive Officer, President And Director; Scott Myers Appointed To The Board Of Directors As Chairperson
Stifel Nicolaus Remains a Buy on Zentalis Pharmaceuticals (ZNTL)
Zentalis Pharmaceuticals: Kimberly Blackwell to Remain as Strategic Advisor to the Bd >ZNTL
Zentalis Pharmaceuticals Scott Myers Appointed to the Bd of Directors as Chairperson >ZNTL
Press Release: Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib
Express News | Zentalis Pharmaceuticals Inc - Julie Eastland Appointed CEO, President and Director